Intuitive Surgical, Inc. (NASDAQ:ISRG) is Bourne Lent Asset Management Inc.’s 7th Largest Position

Bourne Lent Asset Management Inc. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 26,810 shares of the medical equipment provider’s stock after selling 900 shares during the quarter. Intuitive Surgical accounts for approximately 5.3% of Bourne Lent Asset Management Inc.’s holdings, making the stock its 7th biggest holding. Bourne Lent Asset Management Inc.’s holdings in Intuitive Surgical were worth $13,994,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. AE Wealth Management LLC raised its holdings in shares of Intuitive Surgical by 24.5% during the second quarter. AE Wealth Management LLC now owns 3,822 shares of the medical equipment provider’s stock valued at $1,700,000 after acquiring an additional 752 shares in the last quarter. Epoch Investment Partners Inc. lifted its position in shares of Intuitive Surgical by 7.1% in the 2nd quarter. Epoch Investment Partners Inc. now owns 1,036 shares of the medical equipment provider’s stock worth $461,000 after purchasing an additional 69 shares during the period. EverSource Wealth Advisors LLC boosted its position in Intuitive Surgical by 32.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,157 shares of the medical equipment provider’s stock valued at $514,000 after acquiring an additional 281 shares in the last quarter. DRW Securities LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $428,000. Finally, Steel Grove Capital Advisors LLC lifted its stake in shares of Intuitive Surgical by 80.5% in the 2nd quarter. Steel Grove Capital Advisors LLC now owns 1,009 shares of the medical equipment provider’s stock valued at $449,000 after purchasing an additional 450 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent research reports. Mizuho raised their price objective on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research note on Friday, October 18th. Piper Sandler reiterated an “overweight” rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird upped their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 43,509 shares of company stock valued at $22,602,212. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Up 1.9 %

Intuitive Surgical stock opened at $604.12 on Wednesday. The business has a 50-day simple moving average of $541.80 and a two-hundred day simple moving average of $500.76. Intuitive Surgical, Inc. has a 52-week low of $362.14 and a 52-week high of $606.27. The company has a market cap of $215.18 billion, a P/E ratio of 97.13, a P/E/G ratio of 5.04 and a beta of 1.39.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.